An update on the oxazolidinone antibiotics

被引：5

作者：

Abdel-Rahman, SM ^{[1
]}

Kearns, GL ^{[1
]}

机构：

[1] Childrens Mercy Hosp, Kansas City, MO 64108 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1999年 / 18卷 / 12期

关键词：

D O I：

10.1097/00006454-199912000-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：1101 / 1102

页数：2

相关论文

共 15 条

[1] Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections [J].

Brickner, SJ ;

Hutchinson, DK ;

Barbachyn, MR ;

Manninen, PR ;

Ulanowicz, DA ;

Garmon, SA ;

Grega, KC ;

Hendges, SK ;

Toops, DS ;

Ford, CW ;

Zurenko, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :673-679

[2] In vitro activities of new oxazolidinone antimicrobial agents against enterococci [J].

Eliopoulos, GM ;

Wennersten, CB ;

Gold, HS ;

Moellering, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1745-1747

[3] Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds [J].

Jones, RN ;

Low, DE ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) :101-112

[4] CLINICAL PHARMACOKINETICS IN INFANTS AND CHILDREN - A REAPPRAISAL [J].

KEARNS, GL ;

REED, MD .

CLINICAL PHARMACOKINETICS, 1989, 17 :29-67

[5] The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin [J].

Lin, AH ;

Murray, RW ;

Vidmar, TJ ;

Marotti, KR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2127-2131

[6] In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae [J].

Manzor, O ;

Pawlak, J ;

Saravolatz, L .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :31-36

[7] In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae [J].

Mason, EO ;

Lamberth, LB ;

Kaplan, SL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1039-1040

[8] In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium [J].

Mercier, RC ;

Penzak, SR ;

Rybak, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2573-2575

[9] Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium [J].

Rybak, MJ ;

Cappelletty, DM ;

Moldovan, T ;

Aeschlimann, JR ;

Kaatz, GW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :721-724

[10] Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid [J].

Schaadt, RD ;

Batts, DH ;

DaleyYates, PT ;

Pawsey, SD ;

Stalker, DJ ;

Zurenko, GE .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (04) :201-204